PMDA — authorised 23 January 2020
- Marketing authorisation holder: Mochida Pharmaceutical Co., Ltd.
- Status: approved
PMDA authorised Natazia on 23 January 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 January 2020.
Mochida Pharmaceutical Co., Ltd. holds the Japanese marketing authorisation.